In:
Digestive Endoscopy, Wiley, Vol. 35, No. 5 ( 2023-07), p. 658-667
Abstract:
Many studies showed better outcomes of endoscopic ultrasound‐guided gallbladder drainage (EUS‐GBD) when compared with percutaneous transhepatic gallbladder drainage (P‐GBD) in which most tubes were left in situ. However, no studies have directly compared EUS‐GBD with P‐GBD after tube removal (ex situ). We compared the long‐term outcomes of EUS‐GBD and ex situ or in situ P‐GBD in high surgical risk patients with acute cholecystitis. Methods We reviewed the records of 182 patients (EUS‐GBD, n = 75; P‐GBD, n = 107) who underwent gallbladder drainage. The procedural outcomes, long‐term outcomes, and adverse events were compared. Results The EUS‐GBD group and the P‐GBD group had similar rates of technical and clinical success. Early adverse events were less common in the EUS‐GBD group (5.5% vs. 18.9%, P = 0.010). The long‐term outcomes were evaluated in 168 patients (EUS‐GBD, n = 67; P‐GBD ex situ, n = 84; P‐GBD in situ, n = 17). The rate of cholecystitis recurrence in the EUS‐GBD group (6.0%) was similar to that in the P‐GBD ex situ group (9.6%, P = 0.422), but significantly lower than that in the P‐GBD in situ group (23.5%, P = 0.049). P‐GBD in situ was a significant predictor of recurrent cholecystitis (hazard ratio 14.6; 95% confidence interval 2.9–72.8). Conclusion The long‐term recurrence rate of acute cholecystitis in patients who underwent EUS‐GBD was comparable to that in patients whose P‐GBD could be removed. However, patients in whom P‐GBD could not be removed showed higher rates of recurrent cholecystitis than patients with EUS‐GBD.
Type of Medium:
Online Resource
ISSN:
0915-5635
,
1443-1661
Language:
English
Publisher:
Wiley
Publication Date:
2023
detail.hit.zdb_id:
2020071-7
detail.hit.zdb_id:
1171589-3
